Back to GILD
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
3
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA5/27/2021
Efmody
Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.
View on EMAEMA2/9/2018
Alkindi
Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old).
View on EMADrug Science
Mechanism of action & safety profile
Developer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
